139 related articles for article (PubMed ID: 30952752)
1. Assessing the Interleukin 35 Immunoexpression in Malignant Canine Mammary Tumors: Association With Clinicopathological Parameters and Prognosis.
Carvalho MI; Pires I; Prada J; Pinto C; Gregório H; Cogliati B; Queiroga FL
Anticancer Res; 2019 Apr; 39(4):2077-2083. PubMed ID: 30952752
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.
Raposo TP; Pires I; Carvalho MI; Prada J; Argyle DJ; Queiroga FL
Vet Comp Oncol; 2015 Dec; 13(4):464-74. PubMed ID: 24119241
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.
Carvalho MI; Pires I; Dias M; Prada J; Gregório H; Lobo L; Queiroga F
Anal Cell Pathol (Amst); 2015; 2015():920409. PubMed ID: 26346272
[TBL] [Abstract][Full Text] [Related]
6. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
7. Positive Interplay Between CD3+ T-lymphocytes and Concurrent COX-2/EGFR Expression in Canine Malignant Mammary Tumors.
Carvalho MI; Pires I; Prada J; Ferreira AF; Queiroga FL
Anticancer Res; 2015 May; 35(5):2915-20. PubMed ID: 25964576
[TBL] [Abstract][Full Text] [Related]
8. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study.
Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL
Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550
[TBL] [Abstract][Full Text] [Related]
9. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
10. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
11. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study.
Huang J; Zhang D; Xie F; Lin D
J Vet Sci; 2015; 16(2):225-31. PubMed ID: 26124697
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: An immunohistochemical and prognostic study.
Dolka I; Król M; Sapierzyński R
Res Vet Sci; 2016 Apr; 105():124-33. PubMed ID: 27033920
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
[TBL] [Abstract][Full Text] [Related]
15. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
16. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
[TBL] [Abstract][Full Text] [Related]
17. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
[TBL] [Abstract][Full Text] [Related]
18. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
19. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
Dutra AP; Granja NV; Schmitt FC; Cassali GD
Braz J Med Biol Res; 2004 Nov; 37(11):1673-81. PubMed ID: 15517084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
